Live news related to SENSORION stock (FR0012596468): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on SENSORION mainly cover M&A activity et share price moves. The stock trades at €0,22 on Euronext Paris, down 4,61% at the last update. This page lists the articles published on SENSORION stock to track the share price, company announcements and any item likely to influence market perception.
The Montpellier-based biotech details the terms of access to an event dedicated to SENS-601, its flagship gene therapy program targeting a form of gen…
The Montpellier biotech company is advancing to the clinical phase with its lead candidate, a gene therapy targeting a form of genetic deafness for wh…
Biotech company Sensorion announced on Wednesday that it has selected SENS-601, a gene therapy aimed at treating hearing loss associated with mutation…
On Wednesday, March 11, shares of the Montpellier-based biotech company Sensorion surged, showing a 9.98% increase to €0.518 during the session, in a …
